EMA Withdrawn: Prevenar (pneumococcal oligosaccharide serotype 18C;Pneumococcal polysaccharide serotype 19F;Pneumococcal polysaccharide serotype 23F;Pneumococcal polysaccharide serotype 4;Pneumococcal polysaccharide serotype 6B;Pneumococcal polysaccharide serotype 9V;Pneumococcal polysaccharide serotype 14) — Pfizer Limited

View source ↗

Summary

European Medicines Agency withdrew Prevenar from the market (pneumococcal serotypes) handled by Pfizer Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immunization - Pneumococcal Disease
• Pneumococcal Infections

Drugs mentioned

• Prevenar (pneumococcal conjugate vaccine)

Snippet

Status: Withdrawn. Therapeutic area: Pneumococcal Infections;Immunization. MAH: Pfizer Limited. Decision date: 22/06/2015